Clinical Trial Update: ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation [Phase 3]

View source ↗

Summary

ZEUS is a Phase 3 trial evaluating Ziltivekimab versus placebo in people with cardiovascular disease and chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease

Drugs mentioned

• Ziltivekimab

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Cardiovascular Risk, Chronic Kidney Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING